BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 21555626)

  • 1. Intraocular pressure elevation during radioactive plaque brachytherapy for uveal melanoma.
    Bhatia SK; Covert DJ; Wirostko WJ
    Arch Ophthalmol; 2011 May; 129(5):668-9. PubMed ID: 21555626
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of radiation dose on ocular complications after iodine brachytherapy for large uveal melanoma: empirical data and simulation of collimating plaques.
    Puusaari I; Heikkonen J; Kivelä T
    Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3425-34. PubMed ID: 15452045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glaucoma After Iodine-125 Brachytherapy for Uveal Melanoma: Incidence and Risk Factors.
    Kim EA; Salazar D; McCannel CA; Kamrava M; Demanes DJ; Lamb J; Caprioli J; McCannel TA
    J Glaucoma; 2020 Jan; 29(1):1-10. PubMed ID: 31688338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ocular complications after iodine brachytherapy for large uveal melanomas.
    Puusaari I; Heikkonen J; Kivelä T
    Ophthalmology; 2004 Sep; 111(9):1768-77. PubMed ID: 15350335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Periocular triamcinolone for prevention of macular edema after iodine 125 plaque radiotherapy of uveal melanoma.
    Horgan N; Shields CL; Mashayekhi A; Teixeira LF; Materin MA; O'Regan M; Shields JA
    Retina; 2008; 28(7):987-95. PubMed ID: 18698302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iris and anterior chamber angle neovascularization after iodine 125 brachytherapy for uveal melanoma.
    Detorakis ET; Engstrom RE; Wallace R; Straatsma BR
    Ophthalmology; 2005 Mar; 112(3):505-10. PubMed ID: 15745782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strabismus in adults with uveal melanoma following episcleral plaque brachytherapy.
    Dawson E; Sagoo MS; Mehta JS; Comer R; Hungerford J; Lee J
    J AAPOS; 2007 Dec; 11(6):584-8. PubMed ID: 17588793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors predictive of radiation retinopathy post (125)Iodine brachytherapy for uveal melanoma.
    Krema H; Xu W; Payne D; Vasquez LM; Pavlin CJ; Simpson R
    Can J Ophthalmol; 2011 Apr; 46(2):158-63. PubMed ID: 21708084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid exudation following plaque radiotherapy for posterior uveal melanoma.
    Mills MD; Harbour JW
    Am J Ophthalmol; 2006 Mar; 141(3):594-595. PubMed ID: 16490526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pigmented episcleral deposits after brachytherapy of uveal melanoma.
    Toivonen P; Kivelä T
    Ophthalmology; 2006 May; 113(5):865-73. PubMed ID: 16530837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The analysis of I125 brachytherapy complications in cases of uveal melanoma].
    Pogrzebielski A; Starzycka M; Romanowska-Dixon B; Jakubowska B; Szpakowicz U
    Klin Oczna; 2005; 107(1-3):49-53. PubMed ID: 16052800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A choice of radionuclide: Comparative outcomes and toxicity of ruthenium-106 and iodine-125 in the definitive treatment of uveal melanoma.
    Takiar V; Voong KR; Gombos DS; Mourtada F; Rechner LA; Lawyer AA; Morrison WH; Garden AS; Beadle BM
    Pract Radiat Oncol; 2015; 5(3):e169-e176. PubMed ID: 25423888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrastructural alterations in extraocular muscles following iodine-125 brachytherapy for uveal melanoma.
    Kïratlï H; Yïlmaz PT; Sargon M
    Strabismus; 2007; 15(2):103-9. PubMed ID: 17564940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corneoscleral necrosis after episcleral Au-198 brachytherapy of uveal melanoma.
    Chaudhry IA; Liu M; Shamsi FA; Arat YO; Shetlar DJ; Boniuk M
    Retina; 2009 Jan; 29(1):73-9. PubMed ID: 18728617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uveal melanoma radiation. 125I brachytherapy versus helium ion irradiation.
    Char DH; Castro JR; Quivey JM; Phillips TL; Irvine AR; Stone RD; Kroll S
    Ophthalmology; 1989 Dec; 96(12):1708-15. PubMed ID: 2695875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plaque radiotherapy for uveal melanoma.
    Shields JA; Shields CL; De Potter P; Cu-Unjieng A; Hernandez C; Brady LW
    Int Ophthalmol Clin; 1993; 33(3):129-35. PubMed ID: 8407177
    [No Abstract]   [Full Text] [Related]  

  • 17. Ocular motility disturbances after episcleral plaque brachytherapy for uveal melanoma.
    Sener EC; Kiratli H; Gedik S; Sanac AS
    J AAPOS; 2004 Feb; 8(1):38-45. PubMed ID: 14970798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orbital extension of anterior uveal melanoma after Baerveldt tube shunt implantation.
    Sweeney AR; Keene CD; Klesert TR; Jian-Amadi A; Chen PP
    Can J Ophthalmol; 2014 Dec; 49(6):e133-5. PubMed ID: 25433745
    [No Abstract]   [Full Text] [Related]  

  • 19. Incidence of Strabismus Post-Plaque Brachytherapy in Patients With Uveal Melanoma.
    Huang JJ; Saleem A; Liao EX; Larocque M; Menon G; Murtha A; Solarte C; Weis E
    Am J Ophthalmol; 2024 Jun; 262():161-169. PubMed ID: 38307213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 17-year retrospective study of institutional results for eye plaque brachytherapy of uveal melanoma using (125)I, (103)Pd, and (131)Cs and historical perspective.
    Leonard KL; Gagne NL; Mignano JE; Duker JS; Bannon EA; Rivard MJ
    Brachytherapy; 2011; 10(4):331-9. PubMed ID: 21349775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.